Pharmaceutical

Japan grants patent for BioArctic’s Parkinson’s disease antibody

Japan has granted a new drug substance patent for BioArctic’s monoclonal antibody (mAb), BAN0805, to treat Parkinson’s disease.

Aug 24, 2023 - 20:00
Japan grants patent for BioArctic’s Parkinson’s disease antibody
Japan has granted a new drug substance patent for BioArctic’s monoclonal antibody (mAb), BAN0805, to treat Parkinson’s disease.
Read the original article

Tags:

Previous Article

FORE Biotherapeutics raises funding to expedite plixorafenib development

Next Article

Dizal receives approval in China for NSCLC therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Grey Wolf gains $50m boost for antigen modulation tech

Grey Wolf gains $50m boost for antigen modulation tech

May 25, 2024

Sanofi and AstraZeneca to supply additional RSV doses to US

Sanofi and AstraZeneca to supply additional RSV doses t...

Dec 16, 2023

Partnership deals for psychedelic drugs take a trip with 500% surge in 2023

Partnership deals for psychedelic drugs take a trip wit...

Dec 2, 2023